OXiGENE Participates in Cowen & Company 27th Annual Healthcare Conference Available via Webcast

WALTHAM, Mass.--(BUSINESS WIRE)--OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a leading developer of biopharmaceutical compounds to treat cancer and certain ophthalmologic diseases, announced today that Dr. Richard Chin, its President and Chief Executive Officer, will present at the Cowen & Company 27th Annual Healthcare Conference at The Boston Marriott Copley Place Hotel in Boston, MA. Dr. Chin will present on Tuesday, March 13, 2007 at 1:45pm ET.

MORE ON THIS TOPIC